WLYB NYSE Week ended 24 Jul 2026

Weekly Investor Report

John Wiley & Sons B · Communication Services · Publishing

Open interactive chart View report data Download investor PDF
Latest close 50.21 USD
1.3% latest week
Weekly setup

Constructive trend

The weekly trend is active. Price is 29.1% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 1.3%, after a 7.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 35d.

Setup score 70 out of 100
Latest Close 50.21 USD 24 Jul 2026
1W Return 1.3% latest completed week
4W Return 7.5% short-term follow-through
12W Return 21.9% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.3% Latest completed week; four-week move 7.5%. Indicator stack 60/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 63 relevant articles in the latest sentiment read. Event risk 35d Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 29.1% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 1.3%, after a 7.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.73

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.5% over four weeks, 21.9% over 12 weeks, and 30.9% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W1.3%
4W7.5%
12W21.9%
26W57.6%
52W30.9%
Active trend streak14 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.39Latest activity-pressure read.
Pressure change0.2%Four-week change in activity pressure.
Leadership23.17Latest relative-leadership reading.
RS change40.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength94/100Blend of value, momentum, and quality. Underlying universe rank 7; rank 1 is best.
Value83/100Relative valuation strength. Underlying universe rank 18; rank 1 is best.
Quality82/100Profitability and accounting quality. Underlying universe rank 19; rank 1 is best.
Momentum75/100Medium-term price momentum. Underlying universe rank 26; rank 1 is best.
Growth70/100Revenue and earnings growth. Underlying universe rank 31; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
11.5x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
7.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
72.7%
Gross profit retained from each unit of revenue.
Operating margin
16.4%
Operating profit retained from revenue.
Free-cash-flow margin
20.5%
Free cash flow generated from revenue.
Return on invested capital
13.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-0.1%
Latest one-year revenue growth.
EPS growth
163.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
21.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.8%
Cash dividends relative to market value.
Buyback yield
3.9%
Net share repurchases relative to market value.
Shareholder yield
6.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 63 relevant articles.

14 positive · 45 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings35dNext report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.8%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2611 weeks finished lower.
Best week+18.5%Week of 6 Mar.
Worst week-7.5%Week of 20 Mar.
Latest week+1.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks3
Modest losses9
Sharp losses2
Recent vol4.2%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape67/100

Trend, activity pressure, participation, and risk combine to a 67/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 9/12.

Activity pressure 0.95; 2 reversal markers Factors83/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 15; Small Cap Core rank 20 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 63 relevant articles.

John Wiley & Sons A stock hits 52-week high at 53.28 USD Insiders10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

 Earnings35d

Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.

 Research flow1 items

0 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202650.21 USD1.3%38.88 USD37.83 USD1.3923.171.8KOn
17 Jul 202649.58 USD-2.2%38.29 USD37.70 USD1.4821.21788On
10 Jul 202650.72 USD-2.9%37.77 USD37.59 USD1.5222.083.5KOn
3 Jul 202652.23 USD11.8%37.08 USD37.46 USD1.4027.431.4KOn
26 Jun 202646.72 USD3.8%36.39 USD37.32 USD1.3916.53977On
19 Jun 202645.01 USD5.0%36.01 USD37.21 USD1.339.302.7KOn
12 Jun 202642.87 USD-2.9%35.61 USD37.11 USD1.324.541.1KOn
5 Jun 202644.16 USD7.6%35.34 USD37.02 USD1.398.111.9KOn
29 May 202641.05 USD-0.4%35.07 USD36.97 USD1.33-2.121.1KOn
22 May 202641.21 USD-0.6%34.95 USD36.91 USD1.34-0.70702On
15 May 202641.45 USD0.0%34.79 USD36.84 USD1.390.11217On
8 May 202641.45 USD0.6%34.61 USD36.79 USD1.39-0.19957On
1 May 202641.20 USD0.0%34.43 USD36.73 USD1.390.87229On
24 Apr 202641.20 USD5.1%34.37 USD36.68 USD1.371.188.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.